VERACYTE, INC. Capital Leases, Income Statement, Interest Expense
VERACYTE, INC. (VCYT) reported Capital Leases, Income Statement, Interest Expense of $10.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Expense Statement › Interest Expense
us-gaap:CapitalLeasesIncomeStatementInterestExpense · last filed 2017-11-07
- VERACYTE, INC. capital leases, income statement, interest expense for the quarter ending 2017-09-30 was $10.00K.
- VERACYTE, INC. capital leases, income statement, interest expense for the quarter ending 2017-06-30 was $12.00K.
- VERACYTE, INC. capital leases, income statement, interest expense for the quarter ending 2017-03-31 was $12.00K.
- VERACYTE, INC. capital leases, income statement, interest expense for the quarter ending 2016-09-30 was $0.00.
| Period end | Capital Leases, Income Statement, Interest Expense 3 month | Capital Leases, Income Statement, Interest Expense 6 month | Capital Leases, Income Statement, Interest Expense 9 month |
|---|---|---|---|
| 2017-09-30 | $10.00K 10-Q · filed 2017-11-07 | $22.00K derived: sum of 2 quarters · filed 2017-11-07 | $33.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $12.00K 10-Q · filed 2017-07-31 | $23.00K 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $12.00K 10-Q · filed 2017-05-03 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2017-07-31 | $0.00 10-Q · filed 2017-07-31 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |